Discover 1,347 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,347
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
for
Antibody Mediated Rejection of Lung Transplant
Location: 2 recruiting locations
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06990711
Phase1, Recruiting
Active & ResponsiveNew
Early Feasibility Study of Cartilage Defect Repair
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: 1 recruiting location
Sponsor: DiscGenics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07254806
Phase3, Recruiting
Active & ResponsiveNew
Taldefgrobep Alfa in Adults With Overweight and Obesity
for
Obesity, Overweight
Location: 16 recruiting locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07281495
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression